SCHEMBL9183876

SCHEMBL9183876

NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)[O-].NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)[O-].[Cu+2]

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 2/20 0.36
▸ MMP1 P03956 1/20 0.36
▸ TERT O14746 3/20 0.35
▸ SLC15A2 Q16348 1/20 0.35
▸ CD40 P25942 2/20 0.34
▸ PSMB1 P20618 1/20 0.33
▸ PSMB8 P28062 1/20 0.33
▸ PSMB9 P28065 1/20 0.33
▸ PSMB5 P28074 1/20 0.33
▸ PSMB10 P40306 1/20 0.33
▸ PSMB2 P49721 1/20 0.33
▸ DPP8 Q6V1X1 1/20 0.33
▸ DPP9 Q86TI2 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ GNAI3 P08754 1/20 0.33
▸ GNAO1 P09471 1/20 0.33
▸ GNAI1 P63096 1/20 0.33
▸ GHSR Q92847 1/20 0.32
▸ LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7160638 0.90 MMP2 (0.37) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL9200315 0.90 MMP2 (0.39) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL8427968 0.90 MMP2 (0.39) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL9616877 0.90 MMP2 (0.39) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL7160634 0.90 MMP2 (0.37) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL18568245 0.87 MMP2 (0.35) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL29484171 0.87 SLC15A2 (0.41) MMP2TERTSLC15A2CD40PSMB1
SCHEMBL10525648 0.87 CD40 (0.33) MMP2TERTSLC15A2CD40DPP8
SCHEMBL8832640 0.85 TERT (0.43) MMP2MMP1TERTSLC15A2CD40
SCHEMBL9642989 0.85 MMP2 (0.39) MMP2SLC15A2CD40PSMB1PSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0489860-B1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORP (US) 1995-08-02 — — EP claimed
EP-0495877-B1 METHODS AND COMPOSITIONS FOR HEALING BONE PROCYTE CORP (US) 1995-03-22 — — EP claimed
US-5145838-A Peptide derivatives PROCYTE CORPORATION (US) 1992-09-08 — — US claimed
EP-0495877-A1 METHODS AND COMPOSITIONS FOR HEALING BONE. PROCYTE CORP (US) 1992-07-29 — — EP claimed
EP-0489860-A1 METHODS AND COMPOSITIONS FOR HEALING ULCERS. PROCYTE CORP (US) 1992-06-17 — — EP claimed
US-5059588-A METHODS AND COMPOSITIONS FOR HEALING BONE USING GLY HIS LYS: COPPER PROCYTE CORPORATION, INCORPORATED (US) 1991-10-22 — — US claimed
US-5023237-A Using oligopeptide containing glycine, histidine, and lysine PROCYTE CORPORATION (US) 1991-06-11 — — US claimed
WO-1991005797-A1 METHODS AND COMPOSITIONS FOR HEALING BONE PROCYTE CORPORATION (US) 1991-05-02 — — WO claimed
WO-1991003488-A1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORPORATION (US) 1991-03-21 — — WO claimed
EP-0489860-B1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORP (US) 1995-08-02 — — EP disclosed
EP-0495877-B1 METHODS AND COMPOSITIONS FOR HEALING BONE PROCYTE CORP (US) 1995-03-22 — — EP disclosed
US-5145838-A Peptide derivatives PROCYTE CORPORATION (US) 1992-09-08 — — US disclosed
US-5145838-A Peptide derivatives PROCYTE CORPORATION (US) 1992-09-08 — — US disclosed
EP-0495877-A1 METHODS AND COMPOSITIONS FOR HEALING BONE. PROCYTE CORP (US) 1992-07-29 — — EP disclosed
US-5059588-A METHODS AND COMPOSITIONS FOR HEALING BONE USING GLY HIS LYS: COPPER PROCYTE CORPORATION, INCORPORATED (US) 1991-10-22 — — US disclosed
US-5023237-A Using oligopeptide containing glycine, histidine, and lysine PROCYTE CORPORATION (US) 1991-06-11 — — US disclosed
US-5023237-A Using oligopeptide containing glycine, histidine, and lysine PROCYTE CORPORATION (US) 1991-06-11 — — US disclosed
WO-1991005797-A1 METHODS AND COMPOSITIONS FOR HEALING BONE PROCYTE CORPORATION (US) 1991-05-02 — — WO disclosed
WO-1991003488-A1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORPORATION (US) 1991-03-21 — — WO disclosed
WO-1991003488-A1 METHODS AND COMPOSITIONS FOR HEALING ULCERS PROCYTE CORPORATION (US) 1991-03-21 — — WO disclosed
Send feedback